Noble Life Sciences is a preclinical contract research organization (CRO) owned and operated by scientists with decades of experience in drug development. In addition to offering standard services including in-vivo and in-vitro specialized models, Noble's team of scientists implements effective and efficient approaches to help guide your research and development programs.
Noble Life Sciences provides integrated preclinical services designed to accelerate drug development. Services include drug pharmacology, disease models, early safety assessments, biomarker validation and tumor profiling, cell line development, and analytical testing. We are committed to providing a strong scientific foundation to enable your preclinical decisions.
One of the biggest challenges in preclinical research is procuring high quality animal services to support your drug development mission. With a flexible and responsive approach to meeting your needs, Noble offers our clients the highest quality services backed by AAALAC accreditation, OLAW assurance, a USDA license and over 50 years of experience in animal housing and husbandry.